Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Journal of the European Academy of Dermatology and Venereology : JEADV|October 7, 2014
Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruptionK B Gordon, A B Gottlieb, R G Langely, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 20, 2012
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasisR G Langley, K Papp, A B Gottlieb, et al.The British Journal of Dermatology|September 24, 2017
Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studiesK B Gordon, A Blauvelt, P Foley, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 3, 2013
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 studyA B Kimball, K A Papp, Y Wasfi, et al.The American Surgeon|November 1, 1989
Needle holder damage to surgical needlesM R Abidin, J G Thacker, S A Lombardi, et al.Journal of Clinical Anesthesia|January 29, 2019
Academic faculty demonstrate higher well-being than residents: Pennsylvania anesthesiology programs' results of the 2017-2018 ACGME well-being surveyPhillip S Adams, Emily K B Gordon, Abiona Berkeley, et al.Bulletin of Experimental Biology and Medicine|June 23, 2022
Calculation of the Biological Efficiency of the Proton Component from 14.8 MeV Neutron Irradiation in Computational Biology with Help of Video CardsK B Gordon, V O Saburov, S N Koryakin, et al.The British Journal of Dermatology|May 13, 2005
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trialS R Feldman, K B Gordon, M Bala, et al.Medical Education|May 21, 2020
The role of the interview in residency selection: A mixed-methods studyEmily K B Gordon, Justin T Clapp, Sarah J Heins, et al.The British Journal of Dermatology|July 12, 2020
Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2)K B Gordon, R B Warren, A B Gottlieb, et al.Pageof 6